(Q34022294)

30 July 2017

title

Serum PCSK9 Levels Distinguish Individuals Who Do Not Respond to High-Dose Statin Therapy with the Expected Reduction in LDL-C (English)

1 reference

30 July 2017

1 reference

3

Linda S Pescatello

1 reference

30 July 2017

Beth A Taylor

1

1 reference

30 July 2017

Gregory Panza

2

1 reference

30 July 2017

Stuart Chipkin

4

1 reference

30 July 2017

Daniel Gipe

5

1 reference

30 July 2017

Weiping Shao

6

1 reference

30 July 2017

C Michael White

7

1 reference

30 July 2017

Paul D Thompson

8

1 reference

30 July 2017

publication date

17 July 2014

1 reference

30 July 2017

1 reference

30 July 2017

volume

2014

1 reference

30 July 2017

page(s)

140723

1 reference

Creative Commons Attribution 3.0 Unported

30 July 2017

copyright license

start time

1 January 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Effect of statins on skeletal muscle function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4127223

Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4127223

A new method for measurement of total plasma PCSK9: clinical applications

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4127223

Molecular biology of PCSK9: its role in LDL metabolism

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4127223

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4127223

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4127223

Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy

5 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2014%2F140723

Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155%2F2014%2F140723

Therapy with HMG CoA reductase inhibitors: characteristics of the long-term permanence of hypocholesterolemic activity

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25136459

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparison of effects of pitavastatin versus pravastatin on serum proprotein convertase subtilisin/kexin type 9 levels in statin-naive patients with coronary artery disease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25136459

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2014/140723

1 reference

30 July 2017

1 reference

30 July 2017

1 reference